Oct 12, 2026 08:04AM
Oct 8, 2026 04:31AM
Sep 1, 2026 08:02AM
Aug 3, 2026 05:38AM
Jul 29, 2026 04:15PM
May 1, 2026 05:38AM
Apr 29, 2026 04:15PM Bausch Health Co. Inc. (BHC) Tops Q1 EPS by 10c; offers guidance
Apr 27, 2026 04:07AM
Apr 14, 2026 08:02AM
Feb 18, 2026 04:10PM
Jan 26, 2026 08:46AM
Dec 23, 2025 05:37PM
Dec 23, 2025 05:35PM
Dec 12, 2025 04:50PM Bausch + Lomb plans $2.8 billion loan refinancing to cut interest rates
Dec 8, 2025 07:22PM
Dec 1, 2025 07:01AM
Dec 1, 2025 07:00AM
Nov 24, 2025 07:05AM
Nov 24, 2025 07:05AM
Nov 18, 2025 07:00AM
Nov 13, 2025 07:01AM Bausch + Lomb sets three-year growth targets at investor day
Nov 5, 2025 08:03AM
Nov 5, 2025 08:00AM
Oct 30, 2025 12:51AM
Oct 29, 2025 04:05PM
Oct 9, 2025 07:00AM
Sep 30, 2025 08:00AM
Sep 30, 2025 07:00AM Bausch Health to Announce Third Quarter 2025 Results on October 29
Sep 29, 2025 08:00AM
Sep 11, 2025 08:35AM
Sep 11, 2025 08:35AM
Sep 5, 2025 08:02AM
Sep 5, 2025 08:02AM
Aug 26, 2025 08:00AM
Aug 21, 2025 08:02AM Bausch Health expands CABTREO acne treatment to Quebec, Saskatchewan plans
Aug 21, 2025 08:02AM
Aug 15, 2025 02:30PM
Aug 15, 2025 02:30PM
Aug 7, 2025 08:00AM
Jul 30, 2025 05:06PM
Jul 30, 2025 04:47PM
Jul 30, 2025 04:05PM Bausch Health Announces Second Quarter 2025 Results
Jul 29, 2025 07:00AM
Jul 29, 2025 07:00AM
Jul 28, 2025 09:11AM
Jul 28, 2025 09:10AM
Jul 24, 2025 08:02AM
Jul 24, 2025 08:02AM
Jul 10, 2025 05:00PM CORRECTING and REPLACING: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans o
Jul 10, 2025 04:16PM

478,931 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All